www.thearorareport.com
THE ARORA REPORT, Ltd.
HOME OF THE UNIQUE ZYX CHANGE METHOD
DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING
VERIFIABLE PERFORMANCE RECORD
Every closed trade since 2007, without exception, is included in the performance results.
Number of ...
STATUS OF CANCER STOCKS
Per our earlier post, we are short on OSIP from $32.2, SNTA from $3.50and EXEL from $5.35.We are long on PARD from $4.45www.thearorareport.com
THE ARORA REPORT, Ltd.
HOME OF THE UNIQUE ZYX CHANGE METHOD
DEDICATED SOLELY TO ...
ENCOURAGING DATA AT ASCO
Our review of the data presented at 2009 Annual Meeting of the American Society of Clinical Oncology held in Orlando shows that the following stocks may move in response to the data:SNTA,ZIOP,CLDX,EXEL,BVTI,ABII,OGXI,INFI,OSIP AND PARD.If the ...
CHECK OUR PERFORMANCE
